Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

238.91
Delayed Data
As of 4:00pm ET
 +10.39 / +4.55%
Today’s Change
223.02
Today|||52-Week Range
412.24
-22.01%
Year-to-Date
Biogen (BIIB) Stock Up as Bernstein Initiates Coverage
4:00pm / TheStreet.com - Paid Partner Content
RBC sees biopharma 'insulated' from Brexit, says buy Celgene for bounceback
Jun 24 / TheStreet.com - Paid Partner Content
These 3 Biotechs Are Down More Than 36% This Year, and They're Bargains
8:24am / MotleyFool.com - Paid Partner Content
Better Buy: Biogen Inc. vs. Celgene Corporation
Jun 23 / MotleyFool.com - Paid Partner Content
Better Buy: NantKwest, Inc. vs. Ionis Pharmaceuticals
Jun 28 / MotleyFool.com - Paid Partner Content
Cramer: Why Can't We Get Together on Mergers?
Jun 22 / TheStreet.com - Paid Partner Content
Trader's Daily Notebook: If There's a Bounce, It Won't Last Long
Jun 28 / TheStreet.com - Paid Partner Content
Why Biogen Inc. Is Down 22.5% In 2016
Jun 21 / MotleyFool.com - Paid Partner Content
3 Reasons Anavex Stock Could Rise
Jun 27 / MotleyFool.com - Paid Partner Content
These 5 Biotech Stocks Are Ridiculously Cheap
Jun 21 / MotleyFool.com - Paid Partner Content
A Biotech Stock Turnaround Requires an Alzheimer's Drug Miracle
Jun 27 / TheStreet.com - Paid Partner Content
Stock Market News for June 16, 2016
Jun 16 / Zacks.com - Paid Partner Content
Think of This Stock as Buy-ogen
Jun 25 / TheStreet.com - Paid Partner Content
Biogen slips after clinical trial setback
Jun 07 / FT.com - Paid Partner Content
2 Biotech Stocks That Won't Pay a Dividend Anytime Soon, and 1 That Should
Jun 24 / MotleyFool.com - Paid Partner Content